Progyny, Inc. (PGNY)
NASDAQ: PGNY · IEX Real-Time Price · USD
27.79
-0.23 (-0.82%)
At close: Jul 19, 2024, 4:00 PM
28.78
+0.99 (3.56%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
Progyny Revenue
Progyny had revenue of $1.11B in the twelve months ending March 31, 2024, with 26.94% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $278.08M with 7.62% year-over-year growth. In the year 2023, Progyny had annual revenue of $1.09B with 38.34% growth.
Revenue (ttm)
$1.11B
Revenue Growth
+26.94%
P/S Ratio
2.39
Revenue / Employee
$1,958,095
Employees
566
Market Cap
2.65B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.09B | 301.69M | 38.34% |
Dec 31, 2022 | 786.91M | 286.29M | 57.19% |
Dec 31, 2021 | 500.62M | 155.76M | 45.17% |
Dec 31, 2020 | 344.86M | 115.18M | 50.15% |
Dec 31, 2019 | 229.68M | 124.28M | 117.92% |
Dec 31, 2018 | 105.40M | 56.82M | 116.94% |
Dec 31, 2017 | 48.58M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Bausch Health Companies | 8.97B |
Ardent Health Partners | 5.53B |
Astrana Health | 1.45B |
PTC Therapeutics | 927.56M |
Certara | 360.69M |
Kymera Therapeutics | 79.41M |
Agios Pharmaceuticals | 29.40M |
SpringWorks Therapeutics | 26.45M |
PGNY News
- 10 days ago - Assisted Reproductive Technology Market Report 2024-2033: Vitrolife Leads the Competition with 9.8% Share, Followed by Ferring, and Progyny - GlobeNewsWire
- 25 days ago - Progyny, Inc. to Host 2024 Inaugural Investor Day - GlobeNewsWire
- 4 weeks ago - Progyny, Inc. Announces Enhanced Global Services with Acquisition of Apryl - GlobeNewsWire
- 5 weeks ago - Fertility Pioneer and Kindbody Founder Gina Bartasi Returns as CEO to Lead Company's Next Phase of Growth - PRNewsWire
- 6 weeks ago - Progyny, Inc. to Present at Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Progyny's board approves another $100 million stock buyback - Market Watch
- 2 months ago - Progyny, Inc. Announces Additional Share Repurchase Program - GlobeNewsWire
- 2 months ago - Progyny, Inc. to Present at BofA Securities 2024 Healthcare Conference and Leerink Partners Healthcare Crossroads Conference 2024 - GlobeNewsWire